Bereavement Management - Description, Assessment and Care

NCT01292512 | Completed DMC

• 1 other identifier: Bereavement Management.
• Study Type: interventional
• Target: 402
• Locations: 1 country
• Sites: 1

Brief Summary

This study aims to develop a risk assessment tool to identify bereaved in risk of complicated grief reactions and to implement a bereavement management programme in primary health care based on the Dual Process Model of coping with bereavement. Furthermore to enhance bereavement care in general practice and to enhance patients' self-management in bereavement care.

Conditions

Bereavement; Grief

Keywords

Bereavement management; Complicated grief

Outcome Measures

Primary Outcomes (1)

• Effect of the intervention measured by an increase in the diagnosis of complicated grief.

  GPs receive updated information on bereavement related symptoms, how to identify complicated grief, and the Dual Process Model of coping.

  20 months

Secondary Outcomes (1)

• Effect of the intervention measured by register-based data.

  20 months

Study Arms (2)

Intervention group

EXPERIMENTAL

A) Professional level. B) Patient level. Intervention Professional level: General Practitioners (GP) receive updated information on bereavement related symptoms, how to identify complicated grief, and the Dual Process Model (DPM) of coping. GPs receive suggestions on how to provide psycho-educational support for the patient. GPs are informed about the results of the initial assessment of their patient prognostic screening for complicated grief. Patient level: Patients receive updated information on bereavement related symptoms, the DPM of coping and suggestions on when to seek professional help. Patients are informed of the results of their initial assessment of their prognostic grief screening. Patients are encouraged to contact their GP if they worry about handling their bereavement reaction.

Other: Prognostic screening for complicated grief

Control group

OTHER

Treatment as usual (in the Danish health care system).

Other: Prognostic screening for complicated grief

Interventions

Prognostic screening for complicated grief OTHER

Patients in the intervention group are prognostically screened for development of complicated grief to identify those in need of help.

Control group; Intervention group

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• years or older.
• Danish citizen.
• Able to understand and speak Danish.
• Informed consent.
• Mentally able to cooperate

You may not qualify if:

• Patients with known substance abuse.
• Patients with recently (within 5 years) diagnosed psychopathological disorders that trigger psychotic episodes.

Sponsors & Collaborators

• University of Aarhus: lead
• Dæhnfeldt Foundation: collaborator
• TrygFonden, Denmark: collaborator
• Danish Cancer Society: collaborator

Study Sites (1)

Research Unit for General Practice

Aarhus, 8000, Denmark

Location

Related Publications (1)

• Guldin MB, Vedsted P, Jensen AB, Olesen F, Zachariae R. Bereavement care in general practice: a cluster-randomized clinical trial. Fam Pract. 2013 Apr;30(2):134-41. doi: 10.1093/fampra/cms053. Epub 2012 Sep 10.

  PMID: 22964078 DERIVED

Study Officials

• Frede Olesen, Professor

  Research Unit for General Practice, Aarhus University, Denmark

  STUDY CHAIR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: DIAGNOSTIC
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: February 8, 2011
• First Posted: February 9, 2011
• Study Start: June 1, 2009
• Primary Completion: January 1, 2012
• Study Completion: January 1, 2012
• Last Updated: March 27, 2020

Record last verified: 2012-03

Locations

DK (1)